metricas
covid
Enfermedades Infecciosas y Microbiología Clínica (English Edition) Are oral cefuroxime axetil, cefixime and cefditoren pivoxil adequate to treat un...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Are oral cefuroxime axetil, cefixime and cefditoren pivoxil adequate to treat uncomplicated acute pyelonephritis after switching from intravenous therapy? A pharmacokinetic/pharmacodynamic perspective
Cefuroxima axetilo, cefixima y cefditoren pivoxil, ¿son adecuadas en la terapia secuencial de la pielonefritis aguda no complicada? Perspectiva farmacocinética y farmacodinámica
Alicia Rodríguez-Gascóna, Amaia Aguirre-Quiñonerob,
Corresponding author
amayiaguirre@gmail.com

Corresponding author.
, Andrés Canut-Blascob
a Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Centro de Investigación Lascaray Ikergunea, Universidad del País Vasco UPV/EHU, Vitoria, Spain
b Servicio de Microbiología, Hospital Universitario de Álava, Instituto de Investigación Biosanitaria, BioAraba, Vitoria-Gasteiz, Spain
Read
7140
Times
was read the article
2727
Total PDF
4413
Total HTML
Share statistics
Article information
ISSN: 2529993X
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 59 98 157
2025 11 275 257 532
2025 10 242 274 516
2025 9 180 244 424
2025 8 184 320 504
2025 7 246 123 369
2025 6 162 66 228
2025 5 236 109 345
2025 4 148 100 248
2025 3 89 75 164
2025 2 85 65 150
2025 1 86 46 132
2024 12 49 40 89
2024 11 40 29 69
2024 10 30 29 59
2024 9 41 35 76
2024 8 32 29 61
2024 7 20 36 56
2024 6 33 26 59
2024 5 48 22 70
2024 4 31 51 82
2024 3 67 32 99
2024 2 51 42 93
2024 1 64 45 109
2023 12 62 38 100
2023 11 73 29 102
2023 10 107 35 142
2023 9 89 39 128
2023 8 69 23 92
2023 7 71 27 98
2023 6 40 20 60
2023 5 124 54 178
2023 4 93 24 117
2023 3 93 12 105
2023 2 43 12 55
2023 1 47 12 59
2022 12 44 13 57
2022 11 41 8 49
2022 10 35 15 50
2022 9 44 17 61
2022 8 49 7 56
2022 7 32 9 41
2022 6 36 6 42
2022 5 62 13 75
2022 4 39 15 54
2022 3 72 11 83
2022 2 51 7 58
2022 1 93 4 97
2021 12 48 8 56
2021 11 51 17 68
2021 10 64 8 72
2021 9 57 6 63
2021 8 46 6 52
2021 7 33 5 38
2021 6 19 6 25
2021 5 23 8 31
2021 4 36 7 43
2021 3 19 3 22
2021 2 10 10 20
Show all

Follow this link to access the full text of the article